Blood Monitoring Patents For Drug Dosages Rejected By Supreme Court – Huffington Post

"We conclude that the patent claims at issue here effectively claim the underlying laws of nature themselves. The claims are consequently invalid," Breyer wrote in the 24-page opinion. The biotech industry warned the Supreme Court's ruling could ...
Subscribe to LegalLaw247.Com Newsletter

Leave a Reply

Your email address will not be published. Required fields are marked *

*


*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>